• Analyst Coverage
• Corporate Governance
• Email Alerts
• FAQ
• Financial Reports
• Fundamentals
• Image Library
• Information Request
• Investor Events
• SEC Filings
• Presentation Archive
• Press Releases
• Stock Chart
• Stock Quote
• Worth Noting

Current | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

Celera Genomics Signs Five Academic Institution to the Celera Discovery System
Celera Also Signs Three Additional Centers to Existing UT Southwestern Subscription

Rockville, MD - July 19, 2001

Celera Genomics (NYSE: CRA), an Applera Corporation business, announced today it signed multi-year agreements with University of Alabama at Birmingham, Case Western Reserve University School of Medicine, Fred Hutchinson Cancer Research Center, University of Oxford in England, and Pennington Biomedical Research Center at Louisiana State University, which allows these investigators access to Celera’s database products. The subscribers will access Celera's database information and research tools through its Celera Discovery System™.

The University of Texas Health Science Centers at Houston and San Antonio, and the University of Texas Medical Branch now also have access to the Celera databases as part of the existing University of Texas Southwestern Medical Center at Dallas subscription deal signed with Celera in July 2000. Financial terms of the agreements were not disclosed.

The Celera Discovery System is an integrated, web-based platform that enables users to leverage Celera’s computational tools, super-computing power, and the genomic and biological data to advance the discovery process for researchers worldwide.

About Celera
Applera Corporation comprises two operating groups. The Celera Genomics Group, an integrated source of genomic and related medical information headquartered in Rockville, MD, is evolving to become a next generation diagnostic and therapeutic discovery company. Celera intends to leverage its industrialized approach to biology to develop platforms for enabling these new discoveries both for its own internal product development and for its customers, including collaboration partners and subscribers. The Applied Biosystems Group (NYSE:ABI) develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.4 billion during fiscal 2000. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available on the World Wide Web at www.applera.com, or by telephoning 800.762.6923.

Notice To Readers: Celera's press releases, presentations and printed remarks are included on this website for historical purposes only. The information contained in these documents should be considered accurate only as of the date of the relevant document. This information may change over time, and therefore visitors to this website should not assume that the information contained in these documents remains accurate at a later time. We do not have any current intention to update any of the information in these documents.